Biogen has offered to buy all the shares in Sage Therapeutics that it doesn't already own, taking control of their novel antidepressant Zurzuvae. The $7.22-per-share deal for 89.8% of Sage is a 30% ...

Last year, the first phase 3 trial of Sage Therapeutics and Biogen's antidepressant hopeful zuranolone hit its efficacy targets, but raised doubts about the durability of the response. Now, a second ...

Visible from many points along the British Virgin Islands archipelago, Sage Mountain stands at 1,716 feet overlooking Tortola. According to most, BVI's first national park isn't exactly a must-do, but ...